Dumb they ain’t

Since the day Livongo went public achieving an astronomical valuation of over $4 Billion we wonder just what were investors thinking. We knew that digital health was hotter than Georgia asphalt and that the Livongo team had produced in the past, but this didn’t explain why the company achieved such an incredible valuation. From the start we believed, and we continue to believe that the platform offered by Livongo was not new rather it was old fashioned disease management using new technology.

Having witnessed disease management companies flourish then whither we anticipated the same fate for Livongo. After hitting . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.